Israeli biotech company Cannabotech Monday reported the results of a cell model study conducted by doctors at Hadassah Medical Center that examined the efficacy of CannaboBreast products intended to treat breast cancer.
In their own words, the products in combination with chemotherapy would show a six-fold improvement in killing cancer cells compared to existing treatments. From ten percent mortality to sixty percent mortality of cancer cells. Cannabotech develops medical products based on cannabis and fungal extracts.
Cancer treatment with cannabis
the performed experiment showed that it is possible to increase the effectiveness of existing treatments. It is expected that this will also significantly reduce chemotherapy doses, which will reduce the side effects of treatment. In addition, patients can be helped who cannot undergo conventional treatment due to severe side effects.
“This is an important milestone in Cannabotech's growth to become a leader in integrative medicine,” said CEO Elchanan Shaked. “The combination products developed by Cannabotech are aimed at use in various forms of cancer.”
Prof. dr. T Peretz, a senior oncologist who worked on the study, said: “A significant proportion of active cancers are currently being controlled with cannabis in parallel with treatment.” The products are unique because they are developed according to the standards of the pharmaceutical industry and contain different combinations of substances.
Read more jpost.com (Source, EN)
